Reata Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Reata Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 81% to $2,216,000. Profit margin reached -14075%. Total operating expenses were $280,250,000.
Profit Margin
| 2013 | 51.2M | -35.10M | -68.56% |
|---|---|---|---|
| 2014 | 51.95M | 689K | 1.33% |
| 2015 | 50.31M | -1.45M | -2.88% |
| 2016 | 49.85M | -6.22M | -12.49% |
| 2017 | 48.05M | -47.67M | -99.19% |
| 2018 | 53.58M | -80.54M | -150.3% |
| 2019 | 26.51M | -290.17M | -1094.28% |
| 2020 | 9.01M | -247.75M | -2747% |
| 2021 | 11.49M | -297.38M | -2588.22% |
| 2022 | 2.21M | -311.90M | -14074.95% |
RETA Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.21M | 11.49M | 9.01M | 26.51M | 53.58M | 48.05M | 49.85M | 50.31M | 51.95M | 51.2M |
Cost of revenue | 0 | 0 | 0 | 124.39M | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 2.21M | 11.49M | 9.01M | -97.88M | 53.58M | 48.05M | 49.85M | 50.31M | 51.95M | 51.2M |
Operating exp. | ||||||||||
Research and development | 169.84M | 155.99M | 159.08M | 128.10M | 97.28M | 71.27M | 39.45M | 35.14M | 34.30M | 45.25M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 280.25M | 256.19M | 235.34M | 187.33M | 130.46M | 94.97M | 56.73M | 50.65M | 48.32M | 61.58M |
Operating income | -270.15M | -244.70M | -226.32M | -285.22M | -76.87M | -46.91M | -7.09M | -366K | 3.58M | -10.41M |
Other income (expenses), net | -41.77M | -53.12M | -43.91M | -4.94M | 2.53M | -1.19M | 214K | 32K | 86K | 36K |
Income before tax | -311.92M | -297.83M | -270.23M | -290.16M | -80.52M | -47.66M | -6.66M | -302K | 3.66M | -10.34M |
Income tax expense | -25K | -450K | -22.48M | 8K | 26K | 3K | -441K | 1.14M | 2.97M | 24.75M |
Net income | -311.90M | -297.38M | -247.75M | -290.17M | -80.54M | -47.67M | -6.22M | -1.45M | 689K | -35.10M |
Earnings per share | ||||||||||
Basic EPS | -8.59 | -8.19 | -7.35 | -9.54 | -2.91 | -1.99 | -0.31 | -0.26 | 0.13 | -6.38 |
Diluted EPS | -8.59 | -8.19 | -7.35 | -9.54 | -2.91 | -1.99 | -0.31 | -0.26 | 0.03 | -1.76 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |